Vital Signsby BridgeheadAll voices

01  Voice · Sector leader · Rare diseases

Mark Janssen: no licensed photograph is held, so the sector leader plate is shown instead.
Sector leader

Mark Janssen

chairperson of the Dutch Healthcare Institute

Press citations per month · linked articles
1
0
0
0
0
0
0
May 2026JuneJulyAugSeptOctNovto date
1

press citation on 1 topic since 26 May 2026 · last quoted 26 May 2026

02  Quoted on · 1 of 29 topics

Open the topic

Mark Janssen: key facts

Kind of voice
Sector leader
Role
chairperson of the Dutch Healthcare Institute
Quoted on
Rare diseases
Tracked press citations
1
Most recently quoted
26 May 2026

04  The signal · where Mark Janssen sits on rare diseases

Ranked 25= of 231 voices quoted in the press on rare diseases, level with 206 others on 1 citation.

Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.

  1. 1=Vinay PrasadAcademicProfessor of Epidemiology and Biostatistics and Medicine; hematologist-oncologist, University of California, San Francisco (UCSF)4
  2. 1=David WeitzAcademicMallinckrodt Professor of Physics and of Applied Physics; Professor of Systems Biology, Harvard University (John A. Paulson School of Engineering and Applied Sciences)4
  3. 1=Tuomas KnowlesAcademic1920 Professor of Physical Chemistry, University of Cambridge4
  4. 25=Katarina AntonovSector leaderhead of analysis at LIF, the Swedish Association of Research-Based Pharmaceutical Companies1
  5. 25=Oskar AhlbergSector leadervice-president of Rare Disease Sweden1
  6. 25=Mark JanssenSector leaderchairperson of the Dutch Healthcare Institute1
  7. 25=Dr Brian Hon-yin ChungAcademicClinical Associate Professor at The University of Hong Kong and Chief Executive Officer of the Hong Kong Genome Institute1
  8. 25=Dr Francesco CutraleSector leaderCo-Founder and Chief Technology Officer of Kulia Labs Inc.1

Showing the leaders and the ranks around 25=, of 231 voices · See every voice on the topic →

05  On the record · press

What Mark Janssen has said

By outlet · linked articles
  • euractiv.com1

Where Mark Janssen has been quoted

  1. 01Faster drug access as Dutch reduce assessment time for costly medicineseuractiv.com · 26 May 2026

Verbatim

“But we also see drugs that make hardly any difference to someone's health or quality of life, yet are offered at a high price. We therefore do not strive for 100% availability of all new drugs, but for rapid access to good care for everyone.”
chairperson of the Dutch Healthcare Institute · Rare diseases · euractiv.com · 26 May 2026 · Read the article

Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.